E2F1 and diabetes mellitus: Following experimentally induced DM in streptozotocin-treated mice [158,159], streptozotocin-treated rats [160], E2f1/E2f2 mutant mice [161], and non-insulin-dependent KKAy mice [162], early BMSC treatment induced DM reversal.